Exodus Point Capital Management, LP Galapagos Nv Transaction History

Exodus Point Capital Management, LP

  • $14.7 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$51.32 - $68.5 $1.87 Million - $2.49 Million
-36,372 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$47.03 - $57.12 $766,306 - $930,713
16,294 Added 81.15%
36,372 $2.01 Million
Q3 2021

Nov 15, 2021
BUY
$52.17 - $70.2 $1.05 Million - $1.41 Million
20,078 New
20,078 $1.06 Million

Others Institutions Holding GLPG

# of Institutions
90
Shares Held
17.4M
Call Options Held
10.4K
Put Options Held
33.1K
View Full List

About GALAPAGOS NV

GLPG Quotes by TradingView
  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.92B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email